Literature DB >> 29675369

Boxb mediate BALB/c mice corneal inflammation through a TLR4/MyD88-dependent signaling pathway in Aspergillus fumigatus keratitis.

Min Liu1, Cui Li1, Gui-Qiu Zhao1, Jing Lin1, Cheng-Ye Che1, Qiang Xu1, Qian Wang1, Rui Xu1, Ya-Wen Niu1.   

Abstract

AIM: To investigate whether high-mobility group box 1 (HMGB1) Boxb exacerbates BALB/c mice corneal immune responses and inflammatory through the Toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)-dependent signaling pathway in Aspergillus fumigatus (A. fumigatus) keratitis.
METHODS: The mice corneas were pretreated with phosphate buffer saline (PBS), Boxb before A. fumigatus infection. The abdominal cavity extracted macrophages were pretreated with PBS, Boxb, TLR4 inhibitor (CLI-095), Dimethyl sulfoxide (DMSO) separately before A. fumigatus hyphae stimulation. HMGB1 was detected in normal and infected mice corneas and macrophages by real-time reverse transcriptase polymerase chain reaction (RT-PCR), the TLR4, MyD88, interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) were detected by Western blot and PCR.
RESULTS: In BALB/c mice corneas, the expressions of TLR4, HMGB1, IL-1β, TNF-α were increased after A. fumigatus infection. While pretreatment with Boxb significantly increased the expressions of TLR4, HMGB1, MyD88, IL-1β, TNF-α compared with PBS control after infection. In BALB/c mice abdominal cavity extracted macrophages, pretreatment with Boxb increased the expressions of TLR4, HMGB1, MyD88, IL-1β, TNF-α, while pretreatment with CLI-095 and Boxb significantly decreased the expressions of TLR4, HMGB1, MyD88, IL-1β, TNF-α.
CONCLUSION: In A. fumigatus keratitis, Boxb play a pro-inflammatory role in corneal anti-fungi immune response through the HMGB1-TLR4-MyD88 signal pathway.

Entities:  

Keywords:  Aspergillus fumigatus keratitis; Toll-like receptor 4; high-mobility group box 1

Year:  2018        PMID: 29675369      PMCID: PMC5902355          DOI: 10.18240/ijo.2018.04.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  29 in total

Review 1.  HMGB1 as a late mediator of lethal systemic inflammation.

Authors:  H Wang; H Yang; C J Czura; A E Sama; K J Tracey
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 3.  HMGB1 as a cytokine and therapeutic target.

Authors:  Huan Yang; Haichao Wang; Christopher J Czura; Kevin J Tracey
Journal:  J Endotoxin Res       Date:  2002

4.  Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.

Authors:  H Wang; J M Vishnubhakat; O Bloom; M Zhang; M Ombrellino; A Sama; K J Tracey
Journal:  Surgery       Date:  1999-08       Impact factor: 3.982

5.  Effect of corneal graft diameter on therapeutic penetrating keratoplasty for fungal keratitis.

Authors:  Cui Li; Gui-Qiu Zhao; Cheng-Ye Che; Jing Lin; Na Li; Wen-Yan Jia; Qiu-Qiu Zhang; Nan Jiang; Li-Ting Hu
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

6.  HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion.

Authors:  Davide Agnello; Haichao Wang; Huan Yang; Kevin J Tracey; Pietro Ghezzi
Journal:  Cytokine       Date:  2002-05-21       Impact factor: 3.861

7.  Role of TREM-1 in response to Aspergillus fumigatus infection in corneal epithelial cells.

Authors:  Li-ting Hu; Zhao-dong Du; Gui-qiu Zhao; Nan Jiang; Jing Lin; Qian Wang; Qiang Xu; Lin Cong; Sheng Qiu
Journal:  Int Immunopharmacol       Date:  2014-09-19       Impact factor: 4.932

8.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

9.  Surface α-1,3-glucan facilitates fungal stealth infection by interfering with innate immunity in plants.

Authors:  Takashi Fujikawa; Ayumu Sakaguchi; Yoko Nishizawa; Yusuke Kouzai; Eiichi Minami; Shigekazu Yano; Hironori Koga; Tetsuo Meshi; Marie Nishimura
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

10.  Fungal keratitis - improving diagnostics by confocal microscopy.

Authors:  E Nielsen; S Heegaard; J U Prause; A Ivarsen; K L Mortensen; J Hjortdal
Journal:  Case Rep Ophthalmol       Date:  2013-12-19
View more
  5 in total

1.  Expression and role of aryl hydrocarbon receptor in Aspergillus fumigatus keratitis.

Authors:  Li Zhang; Nan Jiang; Gui-Qiu Zhao; Xu-Dong Peng; Guo-Qiang Zhu; Wei Jiang; Jing-Jing Ma
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

Review 2.  Experimental Models for Fungal Keratitis: An Overview of Principles and Protocols.

Authors:  Micaela L Montgomery; Kevin K Fuller
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

3.  MicroRNA-129-5p alleviates spinal cord injury in mice via suppressing the apoptosis and inflammatory response through HMGB1/TLR4/NF-κB pathway.

Authors:  Guang Wan; Yongbo An; Jingang Tao; Yanli Wang; Qinglan Zhou; Rongli Yang; Qiudong Liang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

4.  Aerobic Exercise Inhibits CUMS-Depressed Mice Hippocampal Inflammatory Response via Activating Hippocampal miR-223/TLR4/MyD88-NF-κB Pathway.

Authors:  Honglin Qu; Ruilian Liu; Jiaqin Chen; Lan Zheng; Rui Chen
Journal:  Int J Environ Res Public Health       Date:  2020-04-14       Impact factor: 3.390

5.  Indoleamine 2,3-Dioxygenase Regulates Macrophage Recruitment, Polarization and Phagocytosis in Aspergillus Fumigatus Keratitis.

Authors:  Nan Jiang; Li Zhang; Guiqiu Zhao; Jing Lin; Qian Wang; Qiang Xu; Cui Li; Liting Hu; Xudong Peng; Feifei Yu; Ming Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.